Bullish Moving Averages
12
Bearish Moving Averages
4
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
910.20Today’s High
925.0052W low
508.5052W High
979.90Open Price
913.00Prev. Close
830.1000Volume
1348279.00Value
1232057350.20Fundamentals
Market Cap
88808.40
Price to Earnings
84.00
Price to Book Value
10.60
Dividend Yield
0.10
PE to Growth
-20.20
Op Revenue TTM
5406.02
Net Profit TTM
1057.64
Cash From Operating Activity
1121.80
Return on Equity %
12.57
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
72.5
Week
66.7
Month
55.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
916.33
PIVOT
First Resistance
922.47
Second Resistance
931.13
Third Resistance
937.27
First Support
907.67
Second Support
901.53
Third Support
892.87
Relative Strength Index
56.21
Money Flow Index
47.36
MACD
25.43
MACD Signal
26.68
Average True Range
36.57
Average Directional Index
28.88
Rate of Change (21)
11.13
Rate of Change (125)
32.26
Commodity Channel Index
41.9
Williams %R
-51.4
BETA
1 Month
1.23
3 Month
0.39
1 Year
0.36
3 Year
0.15
PRICE CHANGE ANALYSIS
↓ -0.75%
1 Week
Low
High
891.95
959.9
↑ 17.04%
1 Month
Low
High
760.75
979.9
↑ 11.09%
3 Months
Low
High
743.1
979.9
↑ 23.86%
6 Months
Low
High
694.8
979.9
↑ 53.88%
1 Year
Low
High
508.5
979.9
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 747.88 | 633.43 | 644.91 | 586.36 | 547.93 | 526.01 | 506.30 | 455.32 | 409.11 | 439.87 | 478.11 | |
| Operating Expenses Qtr | 410.68 | 390.60 | 394.04 | 384.00 | 353.50 | 328.44 | 321.82 | 310.27 | 291.53 | 294.10 | 346.17 | |
| Operating Profit Qtr | 199.43 | 200.15 | 202.83 | 159.63 | 153.82 | 153.53 | 152.32 | 116.28 | 89.67 | 103.62 | 103.78 | |
| EBIDT Qtr Cr | 337.20 | 242.83 | 250.87 | 202.36 | 194.43 | 197.57 | 184.48 | 145.05 | 117.58 | 145.77 | 131.94 | |
| Depreciation Qtr | 31.84 | 29.50 | 27.62 | 27.68 | 29.94 | 28.01 | 27.73 | 24.33 | 24.40 | 25.11 | 25.10 | |
| Net Profit Qtr | 241.77 | 158.12 | 161.31 | 126.06 | 126.37 | 122.14 | 358.64 | 85.26 | 66.15 | 103.81 | 73.25 | |
| Basic EPS Qtr | 2.49 | 1.63 | 1.66 | 1.30 | 1.30 | 1.26 | 3.70 | 0.88 | 0.68 | 1.07 | 0.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2612.58 | 2048.83 | 1854.46 | 1137.29 | 125.47 | |
| Operating Expenses Annual Cr | 1579.32 | 1320.57 | 1308.25 | 869.88 | 65.23 | |
| Operating Profit Annual | 762.04 | 584.09 | 420.83 | 160.90 | -5.97 | |
| Operating Profit Margin Annual % | 29.17 | 28.51 | 22.69 | 14.15 | -4.76 | |
| Total Expenses Annual Cr | 1747.62 | 1485.69 | 1451.47 | 1073.08 | 128.57 | |
| EBIDT Annual Cr | 1033.26 | 728.26 | 546.21 | 267.41 | 60.24 | |
| EBIDT Annual margin % | 39.55 | 35.55 | 29.45 | 23.51 | 48.01 | |
| Depreciation | 116.64 | 113.21 | 99.14 | 90.75 | 3.35 | |
| PAT Before ExtraOrdinary Items Annual Cr | 687.26 | 694.31 | 331.13 | -164.45 | -2.96 | |
| Net Profit Annual | 687.26 | 694.31 | 331.13 | -164.45 | -2.96 | |
| Basic EPS Annual | 7.07 | 7.16 | 3.42 | -1.91 | -0.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 7680.76 | 7042.11 | 6309.02 | 5939.43 | 2875.08 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 876.07 | 937.04 | 897.33 | 928.37 | 3.44 | |
| Total Current Liabilities Annual Cr | 512.04 | 441.18 | 295.69 | 275.15 | 674.29 | |
| Total Capital Plus Liabilities Annual Cr | 9068.87 | 8420.33 | 7502.04 | 7142.95 | 3552.81 | |
| Fixed Assets Annual | 4951.91 | 4587.49 | 3207.19 | 2997.30 | 89.71 | |
| Total Non Current Assets Annual | 8042.11 | 6984.28 | 6803.60 | 6181.10 | 756.86 | |
| Total Current Assets Annual | 1026.76 | 1436.05 | 698.44 | 961.85 | 2795.95 | |
| Total Assets Annual | 9068.87 | 8420.33 | 7502.04 | 7142.95 | 3552.81 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 536.28 | 828.08 | 861.12 | 62.04 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 613.09 | 696.47 | 424.57 | 219.24 | -36.12 | |
| Cash from Investing Activity Annual | -805.64 | -842.85 | -733.03 | -344.65 | -2536.25 | |
| Cash from Financing Annual Activity | -245.91 | -54.47 | -75.33 | 396.68 | 2332.24 | |
| Net Cash Flow Annual | - | -200.85 | -383.79 | 271.27 | -240.13 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 79.03 | 72.53 | 65.07 | 61.49 | 53.52 | |
| ROE Annual % | 8.94 | 9.85 | 5.24 | -2.76 | -0.10 | |
| ROCE Annual % | 10.71 | 7.70 | 6.20 | 2.57 | 1.97 | |
| Total Debt to Total Equity Annual | 0.06 | 0.06 | 0.05 | 0.06 | 0.23 | |
| EBDIT Annual Margin % | 44.13 | 38.23 | 31.58 | 25.94 | 101.65 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1468.15 | 1380.99 | 1408.64 | 1326.31 | 1254.73 | 1186.39 | 1162.94 | 1097.78 | 963.51 | 1022.77 | 1049.64 | |
| Operating Expenses Qtr | 1041.37 | 949.11 | 975.81 | 947.61 | 874.17 | 827.79 | 818.20 | 801.91 | 728.54 | 728.33 | 779.28 | |
| Operating Profit Qtr | 381.53 | 385.86 | 387.35 | 337.38 | 340.34 | 313.45 | 318.92 | 264.36 | 210.26 | 245.83 | 239.05 | |
| EBIDT Qtr Cr | 426.78 | 431.88 | 432.83 | 378.70 | 380.56 | 358.60 | 344.74 | 295.87 | 234.97 | 293.34 | 262.43 | |
| Depreciation Qtr | 70.32 | 60.96 | 57.88 | 55.82 | 60.35 | 57.03 | 57.68 | 57.13 | 58.43 | 55.24 | 53.87 | |
| Net Profit Qtr | 251.54 | 289.34 | 276.68 | 240.08 | 250.92 | 222.41 | 457.35 | 172.83 | 123.73 | 189.75 | 144.65 | |
| Basic EPS Qtr | 2.59 | 2.98 | 2.85 | 2.47 | 2.58 | 2.29 | 4.72 | 1.78 | 1.28 | 1.96 | 1.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5584.09 | 4701.84 | 4058.82 | 2619.41 | 1107.11 | |
| Operating Expenses Annual Cr | 3913.90 | 3322.07 | 2988.90 | 2100.81 | 965.45 | |
| Operating Profit Annual | 1492.12 | 1240.53 | 942.56 | 403.86 | 93.58 | |
| Operating Profit Margin Annual % | 26.72 | 26.38 | 23.22 | 15.42 | 8.45 | |
| Total Expenses Annual Cr | 4218.77 | 3638.12 | 3310.89 | 2454.36 | 1094.33 | |
| EBIDT Annual Cr | 1670.19 | 1379.77 | 1069.92 | 518.60 | 141.66 | |
| EBIDT Annual margin % | 29.91 | 29.35 | 26.36 | 19.80 | 12.80 | |
| Depreciation | 244.98 | 232.19 | 221.12 | 174.09 | 45.64 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1057.64 | 1103.51 | 605.05 | -114.50 | 12.91 | |
| Net Profit Annual | 1057.64 | 1103.51 | 605.05 | -137.55 | 58.99 | |
| Basic EPS Annual | 10.89 | 11.36 | 6.24 | -1.59 | 1.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 8408.14 | 7409.54 | 6282.47 | 5638.68 | 2553.15 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 2343.09 | 1646.69 | 2149.39 | 2128.83 | 410.56 | |
| Total Current Liabilities Annual Cr | 1248.71 | 1045.57 | 757.27 | 776.93 | 1009.95 | |
| Total Capital Plus Liabilities Annual Cr | 11999.94 | 10101.85 | 9189.13 | 8544.44 | 3973.66 | |
| Fixed Assets Annual | 6384.26 | 4836.47 | 4714.04 | 4108.65 | 460.92 | |
| Total Non Current Assets Annual | 10293.76 | 8158.78 | 8188.84 | 7419.97 | 1058.27 | |
| Total Current Assets Annual | 1706.18 | 1943.07 | 1000.29 | 1124.47 | 2915.39 | |
| Total Assets Annual | 11999.94 | 10101.85 | 9189.13 | 8544.44 | 3973.66 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 326.66 | 515.17 | 388.01 | 29.07 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1121.80 | 1209.18 | 748.49 | 117.86 | 77.09 | |
| Cash from Investing Activity Annual | -1285.45 | -1187.01 | -771.77 | -73.00 | -2640.70 | |
| Cash from Financing Annual Activity | -263.74 | -288.56 | -294.17 | 191.33 | 2353.12 | |
| Net Cash Flow Annual | - | -266.39 | -317.45 | 236.19 | -210.49 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 86.51 | 76.31 | 64.79 | 58.37 | 47.52 | |
| ROE Annual % | 12.57 | 14.89 | 9.63 | -2.43 | 2.31 | |
| ROCE Annual % | 13.25 | 12.67 | 10.06 | 4.43 | 3.23 | |
| Total Debt to Total Equity Annual | 0.15 | 0.08 | 0.12 | 0.16 | 0.33 | |
| EBDIT Annual Margin % | 30.89 | 30.24 | 27.21 | 20.70 | 13.37 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Hdfc Mutual Fund | 3.18 | 75036288 | - | - |
| SBI Mutual Fund | 2.37 | 75036289 | - | - |
| Canara Robeco Mutual Fund | 1.72 | 75036290 | - | - |
| Government Of Singapore | 7.57 | 75036297 | - | - |
| New World Fund Inc | 5.45 | 75036298 | - | - |
| Smallcap World Fund, Inc | 4.82 | 75036299 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Abhay Soi | 23.74 | 75036282 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Mutual Fund | 3.18 | 75036288 |
| SBI Mutual Fund | 2.37 | 75036289 |
| Canara Robeco Mutual Fund | 1.72 | 75036290 |
| Government Of Singapore | 7.57 | 75036297 |
| New World Fund Inc | 5.45 | 75036298 |
| Smallcap World Fund, Inc | 4.82 | 75036299 |
| Monetary Authority Of Singapore | 1.4 | 75036300 |
| Gqg Partners Emerging Markets Equity Fund | 1.02 | 75036301 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 08, 2023 | 1 | FINAL | Sep 08, 2023 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 22, 2024 | Audited Results & Final Dividend | - |
| Jan 31, 2024 | Quarterly Results | - |
| Nov 06, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 16, 2023 | Audited Results & Final Dividend | - |
| Feb 02, 2023 | Quarterly Results & Others | Inter alia, to consider and approve Proposal for Issue of Non-Convertible Debentures. |
| Nov 01, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results | - |
| Feb 12, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 10, 2021 | Quarterly Results | - |
| May 28, 2021 | Audited Results | - |
| Feb 06, 2021 | Quarterly Results | - |
| Nov 11, 2020 | Quarterly Results | - |
| Sep 01, 2020 | Others | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
Max Healthcare Institute Ltd - 543220 - Commencement Of Operations Of Max Super Speciality Hospital, Dwarka
Commencement of operations of Max Super Speciality Hospital, Dwarka
26 Jun 2024
Max Healthcare Institute Ltd - 543220 - Closure of Trading Window
Closure of Trading Window
12 Jun 2024
Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Conference
05 Jun 2024
Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Conference
29 May 2024
Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call held on May 23, 2024
29 May 2024
Max Healthcare Institute Ltd - 543220 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report
28 May 2024
Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Investor Presentation
Schedule and presentation of Investor Conference
28 May 2024
Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule and presentation of Investor Conference
24 May 2024
Max Healthcare net profit growth down due to higher taxes: Abhay Soi
Abhay Soi, MD & CEO of Max Healthcare, discusses the impact of higher taxes on profitability, emphasizing the shift from EBITDA to free cash flow. He highlights the growth in revenues and EBITDA but a decline in net profit, attributing it to increased tax payments.
